Reply to "¹⁸F-2-fluoro-2-deoxy-d-glucose-positron emission tomography/computed tomography in predicting pathologic complete response after neoadjuvant chemotherapy: the early metabolic response is the answer"

Affiliations

Comment

G Zucchini et al. Eur J Cancer. 2013 Nov.

. 2013 Nov;49(16):3575-6.

doi: 10.1016/j.ejca.2013.08.010. Epub 2013 Sep 4.

¹ Medical Oncology Unit, S. Orsola-Malpighi University Hospital, Bologna, Italy. Electronic address: giorgia.zucchini@studio.unibo.it.

No abstract available

Comment on

Potential utility of early metabolic response by 18F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in a selected group of breast cancer patients receiving preoperative chemotherapy.
Zucchini G, Quercia S, Zamagni C, Santini D, Taffurelli M, Fanti S, Martoni AA. Zucchini G, et al. Eur J Cancer. 2013 May;49(7):1539-45. doi: 10.1016/j.ejca.2012.12.024. Epub 2013 Jan 29. Eur J Cancer. 2013. PMID: 23369464
18F-FDG-PET/CT in predicting pathologic complete response after neoadjuvant chemotherapy: the early metabolic response is the answer.
Sanz-Viedma S, Sanchez-Muñoz A, Scholz-Gutierrez V, Jimenez-Hoyuela JM, Alavi A, Alba E. Sanz-Viedma S, et al. Eur J Cancer. 2013 Nov;49(16):3573-4. doi: 10.1016/j.ejca.2013.07.151. Epub 2013 Sep 16. Eur J Cancer. 2013. PMID: 24051328 No abstract available.